Old Web
English
Sign In
Acemap
>
authorDetail
>
Magnus Christensen
Magnus Christensen
Karolinska Institutet
Pharmacology
Pharmacokinetics
Medicine
CYP1A2
Oral administration
9
Papers
1281
Citations
0.01
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Comparisons of CYP1A2 genetic polymorphisms, enzyme activity and the genotype-phenotype relationship in Swedes and Koreans.
2007
European Journal of Clinical Pharmacology
Roza Ghotbi
Magnus Christensen
Hyung-Keun Roh
Magnus Ingelman Sundberg
Eleni Aklillu
Leif Bertilsson
Show All
Source
Cite
Save
Citations (212)
A common novel CYP2C19 gene variant causes ultrarapid drug metabolism relevant for the drug response to proton pump inhibitors and antidepressants
2006
Clinical Pharmacology & Therapeutics
Sarah C. Sim
Carl Risinger
Marja-Liisa Dahl
Eleni Aklillu
Magnus Christensen
Leif Bertilsson
Magnus Ingelman Sundberg
Show All
Source
Cite
Save
Citations (627)
THE IMPACT OF CYP2C9 GENETICS AND ORAL CONTRACEPTIVES ON CYTOCHROME P450 2C9 PHENOTYPE
2004
Drug Metabolism and Disposition
Mia Sandberg
Inger Johansson
Magnus Christensen
Anders Rane
Erik Eliasson
Show All
Source
Cite
Save
Citations (44)
The karolinska cocktail for phenotyping of five human cytochrome P450 enzymes
2003
Clinical Pharmacology & Therapeutics
Magnus Christensen
Katarina Andersson
Per Dalén
Rajaa A. Mirghani
Gary J. Muirhead
Anna Nordmark
Gunnel Tybring
Anneli Wahlberg
Umit Yasar
Leif Bertilsson
Show All
Source
Cite
Save
Citations (133)
Intra-individual variability in urinary losartan oxidation ratio, an in vivo marker of CYP2C9 activity
2002
British Journal of Clinical Pharmacology
Umit Yasar
Marja-Liisa Dahl
Magnus Christensen
Erik Eliasson
Show All
Source
Cite
Save
Citations (27)
1